Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
May 2016—Bio-Rad Laboratories announced CE IVD marking for its QX200 Droplet Digital PCR System. The technology, which partitions a DNA or RNA sample into 20,000 droplets and amplifies targeted sequences within each droplet, allows scientists to precisely detect and quantify low concentrations of target DNA and RNA sequences.
April 2016—Euroimmun, headquartered in Luebeck, Germany, has developed a system of comprehensive tests available for the serological detection and differentiation of Zika virus infections.
April 2016—Swift Biosciences and SeraCare Life Sciences will partner to accelerate development of a novel circulating tumor DNA reference material.
April 2016—Mikroscan Technologies released the SL5, a real-time telepathology and whole slide imaging solution for use in anatomic pathology applications.
April 2016—Myriad Genetics announced a strategic research collaboration with Tesaro and Merck (known as MSD outside the U.S. and Canada) to help identify potential responders to an investigational combination drug therapy using Tesaro’s PARP inhibitor (niraparib) plus Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy.
April 2016—Illumina has acquired Conexio Genomics, based in Fremantle, Western Australia.
April 2016—Boekel Scientific introduced its Heat Cool Thermal Mixer II, which features a large intuitive touchscreen, interchangeable auto-recognized blocks to fit most laboratory consumables, multiple modes for increased process performance, and a large and accurate temperature and mixing range.
April 2016—Streck’s A1c-Cellular is now assayed for the Ortho-Clinical Diagnostics Vitros 4600. A1c-Cellular is an HbA1c control with intact red blood cells and tests the entire HbA1c procedure, including the lysing of the red blood cell.
April 2016—Leica Biosystems and Advanced Cell Diagnostics announced a comprehensive partnership to develop and commercialize tissue-based diagnostic tests based on ACD’s RNAscope in situ hybridization assays on Leica’s Bond clinical advanced staining instruments.
April 2016—LabStyle Innovations is preparing to launch its FDA-cleared Dario Blood Glucose Monitoring System in the United States.
